McDonald’s will roll out the McPlant burger at around 600 locations in the San Francisco Bay and Dallas-Fort Worth areas for a limited time starting Feb. 14 to learn more about consumer demand for it.
The test began in November with just eight restaurants.
McDonald’s has been cautious in assessing the potential longevity of consumer demand toward meat substitutes, even as rivals like Burger King race to add the item to their menus.
Burger King added the plant-based Impossible Whopper to its menu over two years ago.
The patty for the McPlant burger, which mimics beef’s taste and texture, is made of peas, rice, and potatoes.
The burger, created as part of McDonald's partnership with Beyond Meat, is topped with mayonnaise and American cheese.
Beyond Meat, which represents just a small fraction of McDonald’s 14,000 US restaurants, sees the wider-scale test as a massive opportunity to impress consumers with its meat substitutes.
McDonald’s and Beyond announced a three-year partnership in February. The burger chain has already started selling McPlant burgers in some international markets, including the UK, Austria, Sweden, Denmark, and the Netherlands.


Thailand Inflation Remains Negative for 10th Straight Month in January
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Silver Prices Plunge in Asian Trade as Dollar Strength Triggers Fresh Precious Metals Sell-Off
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns 



